- Home
- JAGX vs LIPO Comparison
JAGX vs LIPO Comparison
Compare JAGX & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- LIPO
- Stock Information
- Founded
- JAGX 2013
- LIPO 2005
- Country
- JAGX United States
- LIPO United States
- Employees
- JAGX N/A
- LIPO N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- JAGX Health Care
- LIPO Health Care
- Exchange
- JAGX Nasdaq
- LIPO Nasdaq
- Market Cap
- JAGX 3.8M
- LIPO 3.1M
- IPO Year
- JAGX N/A
- LIPO 2022
- Fundamental
- Price
- JAGX $10.91
- LIPO $2.65
- Analyst Decision
- JAGX
- LIPO
- Analyst Count
- JAGX 0
- LIPO 0
- Target Price
- JAGX N/A
- LIPO N/A
- AVG Volume (30 Days)
- JAGX 211.5K
- LIPO 176.2K
- Earning Date
- JAGX 05-13-2025
- LIPO 05-08-2025
- Dividend Yield
- JAGX N/A
- LIPO N/A
- EPS Growth
- JAGX N/A
- LIPO N/A
- EPS
- JAGX N/A
- LIPO N/A
- Revenue
- JAGX $11,689,000.00
- LIPO $536,357.00
- Revenue This Year
- JAGX $38.22
- LIPO N/A
- Revenue Next Year
- JAGX $39.96
- LIPO N/A
- P/E Ratio
- JAGX N/A
- LIPO N/A
- Revenue Growth
- JAGX 19.75
- LIPO 19.29
- 52 Week Low
- JAGX $4.02
- LIPO $1.97
- 52 Week High
- JAGX $540.00
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- JAGX 70.55
- LIPO 57.23
- Support Level
- JAGX $5.00
- LIPO $2.25
- Resistance Level
- JAGX $6.13
- LIPO $2.44
- Average True Range (ATR)
- JAGX 1.37
- LIPO 0.22
- MACD
- JAGX 0.94
- LIPO 0.04
- Stochastic Oscillator
- JAGX 60.12
- LIPO 88.39
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.